BREAKING STUDY — COVID mRNA Injection SPIKE Protein inside Cerebral Arteries of STROKE Patients for Up to 17 Months

by Fabio Giuseppe Carlo Carisio
High Risk of Strokes after mRNA Genetic Vaccines and Persistent Spike Protein
A new study published by researchers from Japan’s leading medical universities confirms the extremely high risk of hemorrhagic strokes in cerebral arteries as adverse reactions to Covid vaccines.
But the research is of fundamental and revolutionary importance because it correlates this often lethal pathological event to the long persistence of the toxic Spike protein in the blood.
The Italian online newspaper Gospa News, also published in the International version in English, has been repeatedly censored by fact-checkers and social media precisely for being the first, since 2021, to denounce the dangerousness of mRNA gene serums due to 5 enormous dangers:
- autoimmune diseases in essential organs for the human body such as lungs and heart with risk of turbo-cancer
- neurological and neurocerebral syndromes such as stroke
- long inflammatory persistence of the toxic Spike protein well beyond the 24-48 hours expected by the pharmaceutical companies producing the vaccines and by the health authorities functional to trigger the immune antibody reaction
- myocarditis, thrombosis and other cardiovascular damage caused by blood clots hypothetically related to the presence of graphene oxide and Quantum Dots nanobots in lipid nanoparticles
The Breaking Study from Japanese Medical Universities
Japanese research confirms the suspected but evident correlation between toxic Spike and stroke in the cerebral arteries.
The study was submitted to Science Direct on January 25, 2025, accepted on March 31, and published after review yesterday, April 3, 2025, and will be included in the June 2025 print edition of the Journal of Clinical Neuroscience. The lead author is Nakao Ota, of the Stroke Center, Department of Neurosurgery, Sapporo Teishinkai Hospital, Sapporo, Japan.
HOW COVID VACCINES KILL CHILDREN, WOMEN AND ADULTS. Summary of 100 Global Medical Studies
It is entitled “Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination” and was also signed by other medical researchers from the same structure (Yasuaki Okada, Kosumo Noda, Sadahisa Tokuda, Rokuya Tanikawa) and from other universities such as the Department of Pharmacology, The Jikei University School of Medicine, Tokyo (Masahiko Itani and Tomohiro Aoki), Department of Neurosurgery, Kyoto University School of Medicine (Masahiko Itani and Yoshiki Arakawa), Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo (Aki Sakurai) and Department of Pathology, Sapporo Teishinkai Hospital, Sapporo (Takashi Fujisawa).
“Although the possibility of spike protein expression due to asymptomatic SARS-CoV-2 infection cannot be completely ruled out, this study demonstrated the prolonged presence of the SARS-CoV-2 spike protein in cerebral arteries following mRNA vaccination. In addition, some infiltration of inflammatory cells into spike-positive vessels was observed.”
http://gospanews.net/en//2025/04/03/wuhan-gates-83-china-us-terroristic-plot-on-new-dangerous-covid-strain-nyt-alert-on-hku5-virus-but-it-was-used-in-2014-for-lethal-sars-built-in-north-carolina-biolab/
Let us remember that the Covid-19 virus was also constructed in a laboratory as emerged from the WuhanGates investigations by Gospa News, from dozens of scientific studies published in international journals and from the investigations of the two US Congressional Commissions.
The only sour note in the new Japanese research is the listing of stroke as a “rare adverse reaction” to Covid vaccines, despite 100,000 confirmed cases in the US alone.
Not only that. Even a study by the FDA (Food and Drug Administration, the American drug regulatory body) has confirmed the high risk of strokes, many lethal or disabling, after the combined administration of the mRNA genetic serum together with the flu vaccine.
«Spike protein expression was detected in 43.8 % of vaccinated patients, predominantly localized to the intima of cerebral arteries, even up to 17 months post-vaccination».
«These findings raise significant concerns regarding the biodistribution of lipid nanoparticle-based vaccines and their long-term safety. Global replication studies are urgently required to validate these findings and ensure comprehensive safety evaluations of mRNA vaccines»
This is the bitter conclusion of the Summary of the study that represents further confirmation of two very serious dangers related to mRNA gene sera discovered by two Italian medical scientists: the biochemist Gabriele Segalla who first denounced the inflammatory toxicity of lipid nanoparticles carrying messenger RNA and the bioimmunologist Mauro Mantovani who first reported the persistence of the toxic Spike protein discovering that it was caused by the presence of the “double Proline” inserted by pharmaceutical manufacturers in vaccines.
Fact-Checkers Censorship of Gospa News’ Explosive Scientific Investigations
Precisely for these reasons, Big Pharma-accomplice fact-checkers, who recently even had forced a scientific journal to remove a study on the turbo-cancer alarm in Japan, have censored Gospa News more than any other counter-information voice in the world: because each of our investigations was based on detailed scientific research and not on the vague suppositions of self-styled expert influencers.
Precisely for this reason, Gospa News increasingly needs your support with a donation to continue to unmask the mystifications on vaccines as well as on wars and social policies aimed at anti-Christian Masonic transhumanism.
Fabio Giuseppe Carlo Carisio – Gospa News Director
Implications for hemorrhagic stroke Post-mRNA vaccination
By Nicolas Hulscher, MPH – originally published on his Substack Courageous Discourse
All liks to previous Gospa News investigations have been added in the aftermath by virtue of the ties with the topics higlight below
The study titled, Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination, was published today in the Journal of Clinical Neuroscience:
Background
The rapid deployment of mRNA vaccines for SARS-CoV-2, such as BNT162b2 (BioNTech-Pfizer) and mRNA-1273 (Moderna), provided a critical tool in combating the COVID-19 pandemic. While their short-term safety and efficacy were demonstrated in clinical trials, rare adverse events, including hemorrhagic strokes, have been reported after widespread use. However, the long-term biodistribution and effects of mRNA vaccines remain underexplored.
This study aimed to investigate the long-term presence of SARS-CoV-2 spike protein in brain tissues of patients with hemorrhagic strokes, examining its potential association with mRNA vaccination.
Methods
A total of 19 cases of hemorrhagic stroke from 2023 to 2024 were retrospectively analyzed. Immunohistochemical staining for SARS-CoV-2 spike protein and nucleocapsid protein was performed on tissue samples. In situ hybridization was conducted in selected cases to confirm the origin of spike protein expression (vaccine or viral infection). Vaccination history and SARS-CoV-2 infection status were documented for all cases.
Results
Spike protein expression was detected in 43.8 % of vaccinated patients, predominantly localized to the intima of cerebral arteries, even up to 17 months post-vaccination. While no active inflammatory changes were identified, infiltration of CD4-, CD8- and CD68- positive cells was observed in the spike protein positive vessels. In situ hybridization confirmed the presence of both vaccine-derived mRNA and SARS-CoV-2 virus-derived mRNA, which encode the spike protein, in select cases. Notably, spike protein positivity was observed exclusively in female patients (P = 0.015). None of the cases showed nucleocapsid protein positivity, supporting the absence of active viral infection.
Conclusion
Although the possibility of spike protein expression due to asymptomatic SARS-CoV-2 infection cannot be entirely excluded, this study demonstrated prolonged presence of SARS-CoV-2 spike protein in the cerebral arteries following mRNA vaccination. Additionally, some inflammatory cell infiltration was observed in spike-positive vessels. These findings raise significant concerns regarding the biodistribution of lipid nanoparticle-based vaccines and their long-term safety. Global replication studies are urgently required to validate these findings and ensure comprehensive safety evaluations of mRNA vaccines.
Key points as provided by the authors
Here are the key points as provided by the authors:
- Spike protein expression was detected in 43.8% of vaccinated patients.
- SARS-CoV-2 spike protein persists in cerebral arteries up to 17 months post-vaccination.
- Spike protein was expressed in the intima of the cerebral arteries.
- In situ hybridization confirmed vaccine- and virus-derived spike protein mRNA.
- Findings highlight concerns about mRNA vaccine biodistribution and long-term safety.
These findings are gravely concerning and confirm our suspicions of systemic Spike protein production in vital organs of humans after COVID-19 mRNA injection.
Recently, a study published in Nature Biotechnology found that intramuscular mRNA injection in mice resulted in Spike protein expression in critical organs, including the liver, spleen, lungs, heart, head, and kidneys. Unfortunately, this appears to also be the case in humans.
These extraordinarily dangerous genetic injections must be removed from the market as soon as possible, especially considering that 9 million American children received the latest booster shot. How many of those kids are producing toxic Spike protein in their brain because of ill-advised CDC recommendations?
Epidemiologist and Foundation Administrator, McCullough Foundation – www.mcculloughfnd.org
originally published on his Substack Courageous Discourse
READ MORE BELOW
BREAKING STUDY: Intramuscular mRNA Injections Distribute to Vital Organs, Resulting in Systemic Spike Protein Production
MAIN SOURCES